EDIT vs TER
Editas Medicine Inc (EDIT) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
EDIT currently screens at market cap $375.2M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the EDIT and TER stock pages for the full models.
Not investment advice.